CCM2 antibody
Quick Overview for CCM2 antibody (ABIN2725240)
Target
See all CCM2 AntibodiesReactivity
Host
Clonality
Conjugate
Application
Clone
-
-
Characteristics
- Homo sapiens cerebral cavernous malformation 2 (CCM2), transcript variant 2
-
Purification
- Purified from mouse ascites fluids by affinity chromatography
-
Immunogen
- Full length human recombinant protein of human CCM2(NP_113631) produced in HEK293T cell.
-
Isotype
- IgG1
-
-
-
-
Application Notes
- WB 1:2000, IHC 1:150, IF 1:100,
-
Comment
-
The concentration of the product may vary between diferrent lots.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 0.5-1.0 mg/mL
-
Buffer
- PBS (PH 7.3) containing 1 % BSA, 50 % glycerol and 0.02 % sodium azide.
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- -20 °C
-
-
- CCM2 (Cerebral Cavernous Malformation 2 (CCM2))
-
Alternative Name
- CCM2
-
Background
- This gene encodes a scaffold protein that functions in the stress-activated p38 Mitogen-activated protein kinase (MAPK) signaling cascade. The protein interacts with SMAD specific E3 ubiquitin protein ligase 1 (also known as SMURF1) via a phosphotyrosine binding domain to promote RhoA degradation. The protein is required for normal cytoskeletal structure, cell-cell interactions, and lumen formation in endothelial cells. Mutations in this gene result in cerebral cavernous malformations. Multiple transcript variants encoding different isoforms have been found for this gene.
-
Molecular Weight
- 48.7 kDa
-
Gene ID
- 83605
-
NCBI Accession
- NM_031443
-
HGNC
- 83605
-
Pathways
- Cell-Cell Junction Organization
Target
-